Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
4Cable TV International, Inc. (CATV)
Conway, SC, US
4Cable TV International, Inc. specializes in delivering advanced technological solutions for the cable television sector. Their offerings include RF to Fiber (RF2F), a unique line of taps that convert coaxial signals to fiber, allowing cable providers to broaden their network reach to residential customers. They also provide PowerMiser, an innovative circuitry designed to substantially lower the power consumption of 1 GHz amplifiers and line extenders. Additional products feature RF over Glass (RFoG), a signal distribution method that merges existing cable infrastructure with fiber optics for direct home connections, and Node+0, which combines the capabilities of RFoG and PowerMiser engineering to transmit fiber signals. Furthermore, the company offers SOLAR-CATV, a solar-powered system enabling service expansion into previously unserved territories without requiring additional power sources, and Dynamically Scalable Return technology, which empowers network nodes and RFoG optical network units to adapt their return bandwidth by adjusting the head-end channel configuration. Beyond products, 4Cable TV International also performs repair, diagnostic testing, and system enhancement services. Their products are distributed via a dealer network across the United States and Canada, primarily targeting independent cable TV operators, alongside larger multiple system operators. Founded in 2007, the company's headquarters are located in Conway, South Carolina.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +100.00% | +0.00% | +0.00% | -33.33% | -50.00% | -99.10% | +100.00% | -98.84% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+41.6% ★ Q1'25: +1,545.5% (vs Q1'24)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%-100.0%
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%+17.4% Q1'25: +111.6% (vs Q1'24)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%+6.4% Q1'25: +22.9% (vs Q1'24)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%+0.3% Q1'25: +2.9% (vs Q1'24)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+3.2% Q1'25: -98.5% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×11.16× Q1'25: 2.11× (vs Q1'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Andrew Staniak | 8.04M | 18.04% | 8.04M | — | 8.04M | 10.00 | IN | United States | 2013-10-02 | ↗ |
| 2 | Steven K. Richey | 8.04M | 18.04% | — | 8.04M | — | 10.00 | IN | United States | 2013-10-02 | ↗ |
| 3 | Susan Richey | 8.04M | 18.04% | — | 8.04M | — | 10.00 | IN | United States | 2013-10-02 | ↗ |
| 4 | 46-1906523 | 6.05M | 9.90% | 6.05M | — | 6.05M | — | OO | New York | 2015-07-08 | ↗ |
| 5 | Rickey Luke | 3.78M | 8.48% | 3.78M | — | 3.78M | 10.00 | IN | United States | 2013-10-02 | ↗ |
| 6 | Edmundo Oblenida Carreos | 600.0K | 27.91% | 600.0K | — | 600.0K | 10.00 | IN | Philippines | 2010-06-08 | ↗ |
| 7 | Rosielyn S. Baclig | 600.0K | 27.91% | 600.0K | — | 600.0K | 10.00 | IN | Philippines | 2010-06-08 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Steven K. Richey | President & Director | 41.9K | male |
| Andrew F. Staniak | Chief Technology Officer, Vice President & Director | 21.5K | male |
| Susan Richey | Accounts Payable & Corporate Secretary | 4.2K | female |
| Michael Feldenkrais | Interim Chief Executive Officer | — | male |
| Paul A. Passey | Vice President of Operations | — | male |
| Ross DeMello | Interim Chief Financial Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CATV
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
